Increased FoxM1 expression is a target for metformin in the suppression of EMT in prostate cancer

作者: YIRU WANG , BINWEI YAO , YU WANG , MINGBO ZHANG , SHUAI FU

DOI: 10.3892/IJMM.2014.1707

关键词: OncologyMetforminCancerCancer researchProstate cancerInternal medicineBiologyCell cycleEpithelial–mesenchymal transitionFOXM1OncogeneCell

摘要: Forkhead box M1 (FoxM1) transcription factor is related to the pathogenesis of various malignancies and recent evidence indicates that FoxM1 promotes epithelial-mesenchymal transition (EMT) in breast cancer. Metformin can inhibit progression However, whether plays a role EMT prostate cancer (PCa) metformin suppress through PCa remain unresolved issues. In this study, we investigated expression levels protein 62 39 benign hyperplasia (BPH) samples found were higher tissues (66.1%) compared with BPH (28.2%) (p<0.05). We observed was expressed cell lines suppressed proliferation FoxM1. induced cells by addition transforming growth (TGF)-β1 verified process examining EMT-related gene (E-cadherin, vimentin Slug) expression. addition, knockdown shRNA reversed markedly reduced migration. These results indicate suppresses inhibiting demonstrate suppression may be an effective therapeutic strategy for provide further anticancer effects metformin.

参考文章(41)
Haluk Akpinar, Ilya Gorbachinsky, Dean G Assimos, Metabolic syndrome and urologic diseases. Reviews in urology. ,vol. 12, ,(2010)
Jamila Laoukili, Marie Stahl, René H. Medema, FoxM1: at the crossroads of ageing and cancer. Biochimica et Biophysica Acta. ,vol. 1775, pp. 92- 102 ,(2007) , 10.1016/J.BBCAN.2006.08.006
Aamir Ahmad, Zhiwei Wang, Dejuan Kong, Shadan Ali, Yiwei Li, Sanjeev Banerjee, Raza Ali, Fazlul H. Sarkar, FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors. Breast Cancer Research and Treatment. ,vol. 122, pp. 337- 346 ,(2010) , 10.1007/S10549-009-0572-1
B Dai, S-H Kang, W Gong, M Liu, K D Aldape, R Sawaya, S Huang, Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells Oncogene. ,vol. 26, pp. 6212- 6219 ,(2007) , 10.1038/SJ.ONC.1210443
Mathilde Jalving, Jourik A. Gietema, Joop D. Lefrandt, Steven de Jong, Anna K.L. Reyners, Rijk O.B. Gans, Elisabeth G.E. de Vries, Metformin: taking away the candy for cancer? European Journal of Cancer. ,vol. 46, pp. 2369- 2380 ,(2010) , 10.1016/J.EJCA.2010.06.012
Shan-yang He, Hong-wei Shen, Lin Xu, Xiao-hui Zhao, Li Yuan, Gang Niu, Ze-Shan You, Shu-zhong Yao, FOXM1 promotes tumor cell invasion and correlates with poor prognosis in early-stage cervical cancer. Gynecologic Oncology. ,vol. 127, pp. 601- 610 ,(2012) , 10.1016/J.YGYNO.2012.08.036
Chao Yang, Hui Chen, Guixiang Tan, Wei Gao, Liang Cheng, Xia Jiang, Li Yu, Yongjun Tan, FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer Cancer Letters. ,vol. 340, pp. 104- 112 ,(2013) , 10.1016/J.CANLET.2013.07.004
Nuran Bektas, Anette ten Haaf, Jürgen Veeck, Peter Johannes Wild, Juliane Lüscher-Firzlaff, Arndt Hartmann, Ruth Knüchel, Edgar Dahl, None, Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer. BMC Cancer. ,vol. 8, pp. 42- 42 ,(2008) , 10.1186/1471-2407-8-42